BP
CIM

Boston Provident’s Chimera Investment CIM Stock Holding History

Boston Provident’s Portfolio CIM Stock Details CIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-51,103
Closed -$2.35M – 38
2014
Q1 		$2.35M Hold
51,103
– – 0.84% 28
2013
Q4 		$2.38M Buy
+51,103
New +$2.33M 1.1% 25

Other funds holding CIM

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Boston Provident's CIM Position: Q2 2014 in Review

Boston Provident sold out of Chimera Investment (CIM) in Q2 2014, closing a stake of 51,103 shares — an estimated $2.35M sold.

Boston Provident first reported a position in CIM in Q4 2013 and held it in 2 quarters. The position peaked at $2.38M in Q4 2013. 237 funds tracked by Wall St. Rank hold CIM as of Q2 2014.

  • Boston Provident reported no remaining Chimera Investment position as of Q2 2014 after selling out during the quarter.
  • Boston Provident sold 51,103 Chimera Investment shares in Q2 2014, an estimated $2.35M.
  • Boston Provident first reported a position in Chimera Investment in Q4 2013 and held it in 2 quarters.
  • Boston Provident's Chimera Investment position peaked at $2.38M in Q4 2013.
  • 237 funds tracked by Wall St. Rank held Chimera Investment as of Q2 2014.

Based on Boston Provident's 13F filing for Q2 2014, filed 14 Aug 2014.